New England Research & Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,780
| Closed | -$316K | – | 179 |
|
|
2021
Q1 | $316K | Hold |
3,780
| – | – | 0.17% | 133 |
|
|
2020
Q4 | $345K | Hold |
3,780
| – | – | 0.21% | 123 |
|
|
2020
Q3 | $302K | Hold |
3,780
| – | – | 0.22% | 110 |
|
|
2020
Q2 | $261K | Hold |
3,780
| – | – | 0.19% | 130 |
|
|
2020
Q1 | $238K | Buy |
+3,780
| New | +$238K | 0.2% | 119 |
|
|
2019
Q3 | – | Sell |
-5,250
| Closed | -$323K | – | 168 |
|
|
2019
Q2 | $323K | Buy |
+5,250
| New | +$323K | 0.22% | 131 |
|
|
2018
Q4 | – | Sell |
-13,050
| Closed | -$757K | – | 168 |
|
|
2018
Q3 | $757K | Buy |
+13,050
| New | +$757K | 0.49% | 75 |
|
|
2017
Q4 | – | Sell |
-10,050
| Closed | -$366K | – | 158 |
|
|
2017
Q3 | $366K | Buy |
+10,050
| New | +$366K | 0.27% | 105 |
|